BBHvsETF 2ETF Comparison
VS
Choose a second ETF to run a side-by-side ETF comparison with BBH, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
BBH performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 11/05/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BBH ETF 2 | +4.37%– | +19.27%– | +32.70%– | +38.73%– | +68.11%– | +34.27%– |
| Flows | BBH ETF 2 | +$15M– | +$29M– | +$22M– | +$24M– | -$123M– | -$126M– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BBH ETF 2 | +29.42%– | +22.89%– | +20.65%– | +21.87%– |
| Max drawdown | BBH ETF 2 | -6.32%– | -10.54%– | -22.78%– | -33.06%– |
| Max drawdown duration | BBH ETF 2 | 36d– | 150d– | 440d– | 1456d– |
Trading data
BBH | ETF 2 | |
Last sale 11/5/2026 at 2:30 PM | $251.01 | – |
| Previous close 11/04/2026 | $261.63 | – |
| Consolidated volume 11/04/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of October 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
BBH | ETF 2 | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 11/5/2026 at 2:30 PM
Live
Closed
BBH | ETF 2 | |
|---|---|---|
| Last price | $251.01 | – |
| 1D performance | -4.06% | – |
| AuM | $518.81 M | – |
| E/R | 0.35% | – |
Characteristics
BBH | ETF 2 | |
|---|---|---|
| Management strategy | Passive | – |
| Provider | VanEck | – |
| Benchmark | MVIS US Listed Biotech 25 Index | – |
| N° of holdings | 25 | – |
| Asset class | Equities | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 20, 2011 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
BBH
USA
88.89%
Other
11.11%
ETF 2
Sectors
BBH
Healthcare
100%
Other
-0%
ETF 2
Advertisement
Diversification
BBH
Total weight of top 15 holdings out of 15
85.93%
ETF 2
–
Top 15 holdings
Data as of September 30, 2026
BBH
Amgen, Inc.
15.74%
Gilead Sciences, Inc.
13.28%
Vertex Pharmaceuticals, Inc.
8.21%
Regeneron Pharmaceuticals, Inc.
6.38%
Moderna, Inc.
6.35%
Natera, Inc.
5.31%
argenx SE
4.62%
IQVIA Holdings, Inc.
4.43%
Revolution Medicines, Inc.
4.17%
Illumina, Inc.
3.99%
Guardant Health, Inc.
2.97%
Alnylam Pharmaceuticals, Inc.
2.76%
BeOne Medicines Ltd.
2.74%
Biogen, Inc.
2.73%
Incyte Corp.
2.24%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
